ERBB2 and breast cancer: Initially, we used RNA to determine the expression levels of NF-κB, TWIST1, SIP1, and SLUG in two breast cancer (BC) cell lines, HCC-1954 and MDA-MB-231, classified as HER2+ and triple-negative breast cancer (TNBC) subtypes, respectively.